Skip to main content

Reprieve Cardiovascular

Milford, United States

Reprieve Cardiovascular is focused on improving outcomes for patients suffering from acute decompensated heart failure.

$61.0M raised
Aug 2025
Series B

Top Investors

Lightstone VenturesSante VenturesDeerfield ManagementArboretum VenturesDeerfield

Founder Contacts

19,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Reprieve Cardiovascular

How much funding has Reprieve Cardiovascular raised?
Reprieve Cardiovascular has raised $61.0M in total funding. The most recent round was Series B. The last funding was announced in August 2025.
Who are Reprieve Cardiovascular's investors?
Reprieve Cardiovascular's investors include Lightstone Ventures, Sante Ventures, Deerfield Management, Arboretum Ventures, Deerfield.
Where is Reprieve Cardiovascular headquartered?
Reprieve Cardiovascular is headquartered in Milford, United States.
What does Reprieve Cardiovascular do?
Reprieve Cardiovascular is focused on improving outcomes for patients suffering from acute decompensated heart failure.
What stage is Reprieve Cardiovascular at?
Reprieve Cardiovascular is at the Series B stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Reprieve Cardiovascular — Funding & Investors." VCBacked, August 13, 2025, https://www.vcbacked.co/company/reprieve-cardiovascular. Accessed June 17, 2026.
APA
VCBacked. (2025). Reprieve Cardiovascular — Funding & Investors. Retrieved June 17, 2026, from https://www.vcbacked.co/company/reprieve-cardiovascular
Wikipedia (cite web)
{{cite web |title=Reprieve Cardiovascular — Funding & Investors |url=https://www.vcbacked.co/company/reprieve-cardiovascular |website=VCBacked |access-date=June 17, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .